Related Experiment Video

Updated: Jul 9, 2025

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.0K

Unlocking the potential of platinum drugs: organelle-targeted small-molecule platinum complexes for improved

Zhiqin Deng1,2,3, Shu Chen1,2, Gongyuan Liu1,2

  • 1Department of Chemistry, City University of Hong Kong Hong Kong SAR P. R. China guangzhu@cityu.edu.hk.

RSC Chemical Biology
|November 30, 2023
PubMed

Insights

Organelle-targeted platinum complexes offer a promising strategy to enhance cancer chemotherapy by improving efficacy and overcoming resistance. These targeted platinum drugs show potential for reduced toxicity and novel mechanisms of action.

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Cell Biology

Background:

  • Platinum-based drugs are mainstays in cancer chemotherapy but face limitations like severe side effects and acquired drug resistance.
  • Organelle-targeting strategies represent a novel approach to enhance the therapeutic index of platinum-based anticancer agents.

Purpose of the Study:

  • To review organelle-targeting strategies for platinum complexes in cancer therapy.
  • To discuss mechanisms by which these strategies improve anticancer activity, overcome resistance, and alter drug action.
  • To guide the design and development of novel platinum-based anticancer drugs.

Main Methods:

  • Literature review of organelle-targeting strategies for platinum complexes.
  • Analysis of studies demonstrating enhanced anticancer activity, overcoming resistance, and altered mechanisms.
  • Discussion of design principles for targeted platinum complexes.

Main Results:

  • Organelle-targeted platinum complexes accumulate in specific intracellular sites like the nucleus, mitochondria, endoplasmic reticulum (ER), and lysosomes.
  • Targeting specific organelles enhances anticancer activity and overcomes drug resistance.
  • These strategies can lead to novel molecular mechanisms and potentially reduced toxicity compared to conventional platinum drugs.

Conclusions:

  • Organelle-specific targeting of platinum complexes is a viable strategy to improve cancer chemotherapy.
  • Understanding design principles for targeted platinum delivery is crucial for developing next-generation anticancer agents.
  • This review provides a foundation for researchers to innovate in the field of platinum-based cancer therapeutics.

More Related Videos

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

57.7K
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K